CVS HEALTH CORPORATION and WALMART INC., latest fiscal year, from SEC filings.
| Metric | CVS | WMT |
|---|---|---|
| Revenue | $402.07B FY2025 | $713.16B FY2026 |
| Net income | $1.77B FY2025 | $21.89B FY2026 |
| Net margin | 0.4% FY2025 | 3.1% FY2026 |
| Free cash flow | $7.81B FY2025 | $14.92B FY2026 |
| Total assets | $253.54B FY2025 | $284.67B FY2026 |
| Shareholders' equity | $75.21B FY2025 | $99.62B FY2026 |
| Diluted EPS | $1.39 FY2025 | $2.73 FY2026 |